Head and neck squamous cell carcinoma in patients with Fanconi anemia

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 7, 2005, Pages 640-641

  Van Waes, Carter ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL RECESSIVE DISORDER; AUTOSOME MOSAICISM; BONE MARROW TRANSPLANTATION; CHROMOSOMAL INSTABILITY; CLINICAL FEATURE; ERYTHROPLASIA; FANCONI ANEMIA; GENOMIC INSTABILITY; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPLAKIA; MICROPHTHALMIA; MOLECULAR BIOLOGY; MORTALITY; NOTE; OTORHINOLARYNGOLOGY; SHORT STATURE; SQUAMOUS CELL CARCINOMA; THUMB MALFORMATION;

CARCINOMA, SQUAMOUS CELL; FANCONI ANEMIA; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 23044433550     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.7.640     Document Type: Note

References (17)

1. Alter BP, Joenje H, Ooostra AB, Pals G. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg. 2005;131:635-639.
2. Alter BP. Cancer in Fanconi anemia. Cancer. 2003;97:425-440.
3. Rosenberg PS, Huang Z-G, Alter BP. Cancer Incidence in persons with Fanconi anemia. Blood. 2003;101:822-826.
4. D'Andrea AD. The Fanconi road to cancer. Genes Dev. 2003;17:1933-1936.
5. Bagby GC Jr. Genetic basis of Fanconi anemia. Curr Opin Hematol. 2003;10:68-76.
6. Rosenberg PS, Huang Y, Alter BP. Individualized risks of first adverse events in patients with Fanconi anemia. Blood. 2004;104:350-355.
7. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67-73.
8. Alter BP. Radiosensitivity in Fanconi's anemia patients. Radiother Oncol. 2002;62:345-347.
9. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003;35:165-170.
10. Stavropoulos DJ, Bradshaw PS, Li X, et al. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet. 2002;11:3135-3144.
11. Meetei AR, Yan Z, Wang W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle. 2004;3:179-181.
12. Taniguchi T, D'Andrea AD. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood. 2002;100:2457-2462.
13. Pace P, Johson M, Tan WM, et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 2002;21:3414-3423.
14. Kutler DI, Wreesman VB, Goberdhan A, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2003;95:1718-1721.
15. van Zeeburg HJT, Snijders PJF, Joenje H, Brakenhoff RH. Re: human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2004;96:968-969.
16. Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia - BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003;9:568-574.
17. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene. 2004;23:1000-1004.